Novavax buys Czech vaccine plant, begins vaccine trial in Australia

  In a bid to boost its global vaccine manufacturing abilities, Gaithersburg biotechnology firm Novavax has paid roughly $167 million to buy a biologics manufacturing plant in the Czech Republic. The company paid cash for Praha Vaccines a.s., part of the Cyrus Poonawalla Group. Novavax expects its newly acquired plant in Bohumil, Czech Republic to provide an annual capacity of ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *